DBS for Spasmodic Dysphonia
Palo Alto (17 mi)Overseen byChristopher R Honey, MD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: University of British Columbia
No Placebo Group
Prior Safety Data
Approved in 3 jurisdictions
Trial Summary
What is the purpose of this trial?This trial is testing Deep Brain Stimulation (DBS) for patients with Spasmodic Dysphonia who do not respond well to current treatments. DBS involves placing tiny electrodes in the brain to send electrical signals that help reduce muscle spasms and improve speech. Deep brain stimulation (DBS) is a promising new therapy for patients with spasmodic dysphonia (SD), showing good clinical effects in preliminary trials.
Eligibility Criteria
This trial is for individuals with spasmodic dysphonia who are currently receiving Botox treatments. It's not suitable for those with muscle tension dysphonia, vocal tremor, mild symptoms, neurodegenerative diseases, laryngeal denervation surgery or intracranial pathology. Also excluded are patients with MRI contraindications like metal implants or certain medical devices.Inclusion Criteria
I am currently receiving Botox treatments.
Exclusion Criteria
I have muscle tension in my voice or a shaky voice.
I have had surgery to cut the nerves to my voice box.
I have a condition that causes abnormal bleeding.
I have a condition that affects my brain or nerves.
I do not have any MRI contraindications such as metal implants, certain tattoos, or pregnancy.
I have a brain condition.
Treatment Details
The trial is testing Deep Brain Stimulation (DBS) as a treatment for spasmodic dysphonia. Participants will undergo a surgical procedure to implant electrodes in the brain and receive electrical stimuli to potentially alleviate involuntary muscle contractions affecting speech.
2Treatment groups
Experimental Treatment
Placebo Group
Group I: DBS OnExperimental Treatment1 Intervention
Group II: DBS OffPlacebo Group1 Intervention
Deep Brain Stimulation is already approved in United States, European Union, Canada for the following indications:
πΊπΈ Approved in United States as Deep Brain Stimulation for:
- Essential tremor
- Parkinson's disease
- Dystonia
- Obsessive-compulsive disorder
- Epilepsy
- Chronic pain
- Stroke-related motor deficits (under investigation)
πͺπΊ Approved in European Union as Deep Brain Stimulation for:
- Essential tremor
- Parkinson's disease
- Dystonia
- Obsessive-compulsive disorder
- Epilepsy
- Chronic pain
π¨π¦ Approved in Canada as Deep Brain Stimulation for:
- Essential tremor
- Parkinson's disease
- Dystonia
- Obsessive-compulsive disorder
- Epilepsy
- Chronic pain
Find a clinic near you
Research locations nearbySelect from list below to view details:
Leslie and Gordon Diamond Health Care CenterVancouver, Canada
Loading ...
Who is running the clinical trial?
University of British ColumbiaLead Sponsor